The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognosis of triple negative breast cancer patients who attain pathological complete response with neoadjuvant carboplatin/docetaxel and do not receive adjuvant anthracycline chemotherapy.
 
Priyanka Sharma
Research Funding - Cook Medical (I); GlaxoSmithKline; NinePoint Medical (I); Olympus (I); Roche/Genentech
Travel, Accommodations, Expenses - Novartis
 
Bruce F. Kimler
No Relationships to Disclose
 
Claire Ward
No Relationships to Disclose
 
Anne O'Dea
No Relationships to Disclose
 
Marc Steven Hoffmann
No Relationships to Disclose
 
Jennifer R. Klemp
Leadership - Cancer Survivorship Training
Stock and Other Ownership Interests - Cancer Survivorship Training
Honoraria - Myriad Genetics; Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - I am the founder and CEO of Cancer Survivorship Training, Inc., an online learing company for healthcare providers. The company is the 23rd start-up at the Univ of Kansas and have a license agreement with KU for utilization of my IP.
 
Marilee McGinness
No Relationships to Disclose
 
Jamie Lynn Wagner
No Relationships to Disclose
 
Joshua Mammen
Research Funding - Menorah Legacy Foundation
Travel, Accommodations, Expenses - Ethicon; Johnson & Johnson
 
Amanda Leigh Amin
No Relationships to Disclose
 
Carolyn Lehn
No Relationships to Disclose
 
Roy A. Jensen
Patents, Royalties, Other Intellectual Property - NIH (Inst)
 
Andrew K. Godwin
No Relationships to Disclose
 
Qamar J. Khan
Consulting or Advisory Role - NanoString Technologies; Roche/Genentech
Research Funding - Celgene; Novartis